SPECT/CT of lung nodules using 111In-DOTA-c(RGDfK) in a mouse lung carcinogenesis model

Annals of Nuclear Medicine

Volumn 27, Issue 7, 2013, Pages 640-647

  Hayakawa, Takuya ^a,c   Mutoh, Michihiro ^a   Imai, Toshio ^a   Tsuta, Koji ^b   Yanaka, Akinori ^c   Fujii, Hirofumi ^d   Yoshimoto, Mitsuyoshi ^a,d  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

111In DOTA c(RGDfK); Carcinogenesis; Lung cancer; SPECT

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE N,N',N'',N''' TETRAACETIC ACID CYCLO(ARGINYLGLYCYLASPARTYLPHENYLLYSINIC ACID) INDIUM IN 111; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG CARCINOGENESIS; LUNG HYPERPLASIA; LUNG NODULE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UPREGULATION;

ANIMALS; AUTORADIOGRAPHY; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHAVBETA3; LUNG NEOPLASMS; MALE; MICE; MULTIMODAL IMAGING; MUTATION; ORGANOMETALLIC COMPOUNDS; PEPTIDES, CYCLIC; PROTO-ONCOGENE PROTEINS P21(RAS); TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; URETHANE;

EID: 84882660457     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-013-0729-1     Document Type: Article

References (21)

1. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100:1672-94.
2. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409.
3. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology. 2005;237:395-400.
4. Hori Y, Takasuka N, Mutoh M, Kitahashi T, Kojima S, Imaida K, et al. Periodic analysis of urethane-induced pulmonary tumors in living A/J mice by respiration-gated X-ray microcomputed tomography. Cancer Sci. 2008;99:1774-7.
5. Brooks PC. Role of integrins in angiogenesis. Eur J Cancer. 1996;32A:2423-9.
6. 3 for angiogenesis. Science. 1994;264:569-71.
7. Mizejewski GJ. Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med. 1999;222:124-38.
8. 3 antagonist cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models. Int J Radiat Oncol Biol Phys. 2006;65:1536-43.
9. 3 expression. Cancer Metastasis Rev. 2008;27:631-44.
10. 18F]Galacto-RGD. PLoS Med. 2005;2:e70.
11. 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res. 2001;61:1781-5.
12. 3 Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide. Int J Cancer. 2008;123:709-15.
13. 111In-DOTA-c(RGDfK) to detect early pancreatic cancer in a hamster pancreatic carcinogenesis model. J Nucl Med. 2012;53:765-71.
14. Festing MF, Lin L, Devereux TR, Gao F, Yang A, Anna CH, et al. At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J × BALB/c mice. Genomics. 1998;53:129-36.
15. Gariboldi M, Manenti G, Canzian F, Falvella FS, Radice MT, Pierotti MA, et al. A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat Genet. 1993;3:132-6.
16. 4. Nucl Med Biol. 2011;38:529-40.
17. 3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Res. 2006;8:R20.
18. 3 modulates bone metastatic growth and tissue remodeling. Oncogene. 2007;26:6238-43.
19. 3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis. Pancreas. 2002;25:e30-5.
20. 2 scintigraphy. Eur J Nucl Med Mol Imaging. 2011;38:2145-52.
21. 99mTc-3PRGD2 for integrin receptor imaging of lung cancer: a multicenter study. J Nucl Med. 2012;53:716-22.